Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459595) titled 'Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study' on March 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Fatima Tariq

Condition: Polycystic Ovarian Syndrome (PCOS)

Intervention: Drug: Myoinositol

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: May 1, 2026

Target Sample Size: 60

Countries of Recruitment: Pakistan

To know more, visit https://clinicaltrials.gov/study/NCT07459595

Published ...